Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group
Torsten O. Nielsen(BC Cancer Agency), Daniel F. Hayes(University of Michigan)
Cited by 713
Related Papers
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma
|Clinical Cancer Research|2004|2.7k
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
|Clinical Cancer Research|2008|1.2k
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
|Clinical Cancer Research|2010|823
CD8+ lymphocyte infiltration is an independent favorable prognostic indicator in basal-like breast cancer
|Breast Cancer Research|2012|432
Prediction of Postchemotherapy Ovarian Function Using Markers of Ovarian Reserve
|The Oncologist|2013|63